A Safety Study of LY3526318 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study of LY3493269 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
A Study of LY3502970 in Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Glucose Control in Participants With Type 1 and Type 2 Diabetes
- Status
- WITHDRAWN
- Phase
- N/A
Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss
- Status
- COMPLETED
- Phase
- PHASE3
French National Cohort of People With Type 1 Diabetes
- Status
- RECRUITING
- Phase
- N/A
A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight
- Status
- COMPLETED
- Phase
- PHASE3
At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19
- Status
- TERMINATED
- Phase
- PHASE4
A Study of LY3041658 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3537031 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3484356 in Women With Breast Cancer Before Having Surgery
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3561774 in Participants With Dyslipidemia
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness
- Status
- COMPLETED
- Phase
- PHASE2